Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Specific RNA binding proteins constructed from zinc fingers

W J Friesen1, M K Darby

  • 1Department of Microbiology and Immunology, Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

Nature Structural Biology
|July 17, 1998
PubMed
Summary

Researchers engineered novel RNA-binding proteins using zinc finger technology. These engineered proteins demonstrate specific RNA binding in vitro and in vivo, showcasing altered RNA substrate specificity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The methylosome, a 20S complex containing JBP1 and pICln, produces dimethylarginine-modified Sm proteins.

Molecular and cellular biology·2001
Same author

SMN, the product of the spinal muscular atrophy gene, binds preferentially to dimethylarginine-containing protein targets.

Molecular cell·2001
Same author

Specific RNA binding by a single C2H2 zinc finger.

The Journal of biological chemistry·2000
Same author

Specific sequences of the Sm and Sm-like (Lsm) proteins mediate their interaction with the spinal muscular atrophy disease gene product (SMN).

The Journal of biological chemistry·2000
Same author

The role of zinc finger linkers in p43 and TFIIIA binding to 5S rRNA and DNA.

Nucleic acids research·1998
Same author

Phage display of RNA binding zinc fingers from transcription factor IIIA.

The Journal of biological chemistry·1997

Area of Science:

  • Molecular Biology
  • Protein Engineering
  • RNA-Protein Interactions

Background:

  • Zinc finger proteins are versatile DNA-binding proteins that can be engineered for RNA binding.
  • Targeting specific RNA structures, such as the human immunodeficiency virus type-1 (HIV-1) Rev response element stem loop IIB (RRE-IIB) RNA, is crucial for understanding gene regulation and developing antiviral strategies.
  • Existing methods for isolating RNA-binding proteins have limitations in achieving high specificity and affinity.

Purpose of the Study:

  • To develop a method for engineering novel RNA-binding proteins with altered substrate specificity.
  • To isolate and characterize zinc finger proteins capable of specifically binding target RNA molecules.
  • To demonstrate the feasibility of modifying alpha-helices within zinc finger proteins to achieve desired RNA-binding properties.

Related Experiment Videos

Main Methods:

  • Construction of a bacteriophage-displayed zinc finger library with degenerate alpha-helices.
  • Affinity selection of proteins binding to RRE-IIB RNA and 5S ribosomal RNA (rRNA).
  • In vitro DNA shuffling of affinity-selected zinc finger genes to enhance RNA-binding affinity.
  • Validation of RNA binding specificity in vitro and in vivo.

Main Results:

  • Isolation of zinc finger proteins that specifically bind to RRE-IIB RNA and 5S rRNA.
  • Successful enhancement of RNA-binding affinity through in vitro recombination (DNA shuffling).
  • Demonstration of specific RNA binding by the engineered proteins in both cell-free systems and living cells.
  • Confirmation that mutations in alpha-helices can alter the RNA substrate specificity of zinc finger proteins.

Conclusions:

  • Bacteriophage display and DNA shuffling are effective strategies for engineering novel RNA-binding proteins.
  • Engineered zinc finger proteins can be tailored to bind specific RNA targets with high affinity and specificity.
  • This approach provides a powerful platform for constructing custom RNA-binding proteins for research and therapeutic applications.